More importantly, up to 10% of T-ALL cases harbor activating mutations in genes encoding different molecular effectors downstream of IL-7R signaling, including JAK1, JAK3 and STAT5B (reviewed in [199]), reinforcing the role of IL-7R in leukemia cell proliferation. The gene discussed is IL7R; the disease is leukemia.